Red light therapy for oral lichen planus has become one of the more closely studied alternatives to steroid treatment. For anyone living with the burning, the raw patches, and the cycle of relief and relapse, that research is worth understanding. Oral lichen planus (OLP) is a chronic, immune-driven inflammation of the mouth lining. It produces painful white streaks, red raw areas, and ulcers, most often on the inner cheeks, gums, and tongue. The standard first-line treatment, topical corticosteroids, calms the inflammation but tends to lose ground over time and carries its own drawbacks. Red light therapy, known clinically as photobiomodulation, takes a different route: it works with the body's own cellular repair processes rather than suppressing symptoms from the surface.
Key Takeaways
- Six systematic reviews and multiple randomized trials from 2017 to 2025 found that red light therapy (photobiomodulation) performed about as well as topical corticosteroids for oral lichen planus pain and lesion severity. No adverse effects were reported in the photobiomodulation groups.
- A 2025 meta-analysis linked photobiomodulation to lower OLP recurrence (roughly 57% lower) and higher cure rates (roughly 47% higher) than corticosteroids. A double-blind randomized trial found it as effective as the potent steroid clobetasol with no reported side effects.
What Is Oral Lichen Planus, and Why It Matters
Oral lichen planus is not a passing irritation. It is a condition in which the immune system attacks the cells lining the mouth, producing chronic inflammation, tissue breakdown, and sores that can persist for years. The erosive and atrophic forms (where the tissue is visibly raw and ulcerated) cause the most pain and the most concern, because they carry the highest risk of turning malignant over time.
It is also more common than many people assume. A systematic review and meta-analysis by González-Moles and colleagues (2021) in Oral Diseases put the worldwide prevalence at roughly 1%. Cases rise sharply after age 40 and affect women more often. The World Health Organization classifies OLP as a potentially malignant disorder, with a malignant transformation rate of about 1.1 to 1.4%.
The burden is not only physical. A systematic review by de Porras-Carrique and colleagues (2021) in Clinical Oral Investigations found that most OLP patients experience anxiety, with many also reporting depression and elevated stress. Pain while eating, speaking, and brushing feeds a loop: the condition wears on quality of life, stress aggravates the disease, and avoiding oral care lets other problems pile up.
The standard treatment is topical corticosteroids: clobetasol, triamcinolone, or dexamethasone applied to the lesions. A 2022 systematic review by Sandhu and colleagues in BMC Oral Health mapped the treatment landscape across 70 randomized trials. It confirmed topical steroids as first-line therapy, with other immune-suppressing drugs as second-line. It also recognized photobiomodulation as an evidence-supported alternative, a sign the research base had grown large enough to sit alongside the drug options. The reason patients and clinicians keep looking past steroids is practical: the response can fade with repeated courses, long-term use thins the tissue and invites yeast infection, and the disease usually returns once treatment stops.
Clinical attention has shifted toward photobiomodulation because the gap is specific: steroids can control the symptoms, but for many patients the relief doesn't outlast the prescription.
How Red Light Therapy Works for Oral Lichen Planus
Red light therapy, clinically called photobiomodulation (PBM), uses red and near-infrared light in the range of roughly 630 to 980 nm. This light passes into the mouth lining and is absorbed by the mitochondria, the energy-producing parts of cells. That absorption sets off a chain of effects: cells produce more usable energy, oxidative stress falls, inflammatory signaling quiets down, and tissue repair speeds up. Hundreds of studies describe this basic mechanism. Widely cited reviews by Hamblin (2016) and Maghfour and colleagues (2024) in the Journal of the American Academy of Dermatology summarize the evidence.
For OLP specifically, researchers have gone past the general mechanism and measured how light therapy changes the diseased tissue itself.
Calming the inflammation
OLP is driven by an overactive immune response, and several inflammation signals rise and fall with how severe the disease is. Mutafchieva and colleagues (2024) in Biomedicines measured these signals in the saliva of OLP patients before and after photobiomodulation with an 810 nm dental laser. The treatment lowered the key inflammation markers, and about 60% of patients showed improvement at the tissue level, not just in how they felt. This is a small study without a comparison group, so the tier is modest, but it looks directly at the disease rather than borrowing from another condition.
The anti-inflammatory effect has been documented well beyond the mouth, which helps explain the mechanism even though it comes from other settings. A 2022 double-blind randomized trial by Marashian and colleagues in Frontiers in Immunology, conducted in hospitalized COVID-19 patients, found that light therapy cut two major inflammation signals by roughly 82% each compared with placebo. A separate 2025 laboratory study by Rodriguez and colleagues showed light therapy shifting human immune cells from an inflammatory state toward a repair state. These are different contexts than OLP and should be read as mechanism support, not OLP outcomes.
Not every study found the biomarker shift, though. Abboud and colleagues (2021) in Oral Diseases found that photobiomodulation improved patients' pain and clinical scores, yet the salivary inflammation markers had not measurably shifted by the end of treatment. The clinical benefit was clear; the marker change at that time point was not. The fair summary is that light therapy influences inflammation across many tissues, with supportive but not unanimous biomarker data inside OLP itself.
The thing that stands out in this research is how consistently photobiomodulation holds up against corticosteroids, and with essentially no adverse events. We're past the point of just symptom scores now. The newer studies are showing tissue-level changes: inflammatory markers dropping, cell turnover correcting, oxidative stress improving in the actual lesions. For patients who've been managing OLP with steroids and hitting the wall with recurrence or side effects, this evidence gives them something concrete to bring to their provider.— Dr. Sutherland, DDS
Rebalancing cell loss and repair
A defining feature of OLP is that the immune attack kills too many cells in the mouth lining while also slowing the renewal that should replace them. The result is chronic, slow-to-heal damage. Mutafchieva and colleagues (2025) in Photodiagnosis and Photodynamic Therapy measured markers of cell survival and active cell division in OLP tissue before and after treatment. In the lesions, both were lower than in healthy tissue: cells dying faster and renewing slower than they should. After photobiomodulation, both moved back toward healthy levels, with erosive lesions responding better than the white, thickened kind. A companion study from the same group (2024) in the Dentistry Journal found that treatment corrected a regeneration signal that OLP depletes, and reported clinical improvement in 90% of cases.
Easing oxidative stress
Oxidative stress (an imbalance between damaging molecules and the body's defenses) runs high in OLP tissue and is tied to both symptoms and malignancy risk. The most direct evidence comes from a 2024 randomized controlled trial by Mohamed and colleagues in BMC Oral Health, which compared photobiomodulation (980 nm) with the steroid triamcinolone in 44 OLP patients. Both produced similar improvements in pain and clinical scores. Both also significantly reduced a marker of oxidative damage in saliva. Light therapy matched the steroid's effect on this measure without the steroid's downsides. Supporting work in other settings, such as a 2022 review by de Marchi and colleagues in Antioxidants, shows the same pattern holds across tissues.
Helping the lining heal
The erosive forms of OLP involve slow-healing wounds in the mouth, and mechanical irritation from sharp teeth or dentures can trigger new ones. Light therapy cannot remove the source of irritation, but it can speed the tissue's own repair. A 2021 double-blind trial by Pasquale and colleagues in Applied Sciences tested photobiomodulation on a different painful mouth ulcer (major aphthous ulcers) and found it shortened healing time substantially versus placebo. Aphthous ulcers differ from OLP in how they arise, so this stands as supporting evidence for the healing response rather than a direct OLP result. (For more on red light and oral tissue repair, see Red Light Therapy for Oral Wound Healing: Scientific Research.)
What the Clinical Trials Show: Red Light Therapy vs. Corticosteroids
Across the trials, photobiomodulation performs about as well as topical steroids on pain and lesion severity, with its clearest advantages showing up in recurrence and safety.
The systematic reviews and meta-analyses
Mahuli and colleagues (2024) in the Journal of Stomatology, Oral and Maxillofacial Surgery used GRADE (a formal method for rating how trustworthy evidence is) to assess the research. They found photobiomodulation favored over topical corticosteroids for pain, with the certainty rated moderate. The authors also noted that most underlying trials carried a high risk of bias, an important caveat that travels with this whole literature.
Liu and colleagues (2025) in Lasers in Medical Science is the largest and most recent review, covering 742 participants across 16 studies, though that total spans two different laser approaches. Looking only at photobiomodulation, pain relief was comparable to steroids rather than clearly better (the difference was not statistically significant). Photobiomodulation was linked to about 57% lower recurrence and about 47% higher cure rates. It was most effective at lower energy doses (below 120 J/cm²), and no adverse reactions occurred in the photobiomodulation groups. One note: the review's standout pain result belonged to high-intensity laser therapy, a different technique that uses heat. That is not what at-home red light involves, so it should not be read as a photobiomodulation finding.
Soh and colleagues (2024) in the European Journal of Dentistry took the most cautious view, concluding that photobiomodulation was as effective as comparison treatments but not superior, and calling it a promising alternative. This review included observational studies and a smaller patient pool, which helps explain its more conservative read.
Al-Maweri and colleagues (2017) in Lasers in Medical Science was the first review dedicated to this question. Every included study found light therapy effective for symptomatic OLP, with no adverse effects, and the authors concluded it could be used as an alternative to corticosteroids. The direction identified in that early review has held through every subsequent analysis.
A sixth review widens the picture: de Carvalho and colleagues (2022) in Clinical Oral Investigations analyzed photobiomodulation for autoimmune gingival lesions, including the gum-based form of OLP that many patients have. It found no significant difference between light therapy and topical steroids on pain, another equivalence result, while documenting meaningful pain reduction over the course of treatment.
The strongest individual trials
Ferri and colleagues (2021) in Oral Diseases ran the most rigorous study in this field: a randomized, double-blind, head-to-head trial of photobiomodulation against the steroid clobetasol. Both groups received a real treatment plus a sham version of the other, so neither patients nor evaluators knew which arm they were in. Photobiomodulation (660 nm) proved as effective as clobetasol for pain and clinical scores, with similar resolution and recurrence through 90 days and no adverse effects.
Dillenburg and colleagues (2014) in the Journal of Biomedical Optics compared photobiomodulation with topical clobetasol in 42 patients. Light therapy came out ahead: a higher complete-resolution rate and no recurrence at follow-up. The steroid group worsened after treatment ended. Roccon and colleagues (2023) in Lasers in Medical Science found that even a single session meaningfully reduced pain, with the benefit lasting through 30 days.
Two newer reports add useful angles. Ruiz Roca and colleagues (2022) in the Dentistry Journal reviewed photobiomodulation specifically for the painful atrophic-erosive form and noted that results across studies were not always consistent. Khatoon and colleagues (2025) in the Journal of Lasers in Medical Sciences reported a small series of six patients, including three with erosive disease that had resisted standard treatment. All saw their burning resolve and their ulcers heal, with no recurrence over six months. As a six-patient series the weight is limited, but it speaks directly to the steroid-resistant patient.
What About Blue Light?
Blue light has real antibacterial uses in the mouth; it can kill specific bacteria, which makes it relevant to conditions like gum disease and bad breath. For oral lichen planus, though, there is no evidence for blue light on its own. Every published study pairing blue light with OLP added a light-activated chemical to create photodynamic therapy, which is a fundamentally different treatment. Without that added chemical, blue light has not been tested against OLP. The OLP evidence base is red and near-infrared photobiomodulation. (For blue light's antibacterial role in gum disease, see CuraYou's Oral Health research library.)
Should You Consider Red Light Therapy for Oral Lichen Planus?
The research tells a clear and measured story. Across six systematic reviews and multiple high-quality trials, red light therapy has performed about as well as the standard steroid treatment for pain and lesion severity. It shows signs of lower recurrence and a consistently clean safety record (no adverse effects reported in the light-therapy groups). Tissue-level data shows it acts on the inflammation, cell turnover, and oxidative stress that sustain the disease.
For people who cycle through steroids that work and then fade, who deal with long-term side effects, or who want a drug-free option alongside their care, the evidence is substantial. Red light therapy is worth discussing with a clinician. The biological case is that it works with the body's repair processes rather than only masking symptoms, and you now have the research to weigh that decision for yourself. (For more on red light therapy and dental pain, see Red and Blue Light Therapy for Dental Pain: Scientific Research. For building a science-based routine, see The Best Oral Care Routine for Adults in 2026.)
